Year: 2018

A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of topical Lidocaine Spray in Patients with Postherpetic Neuralgia.
A double-blind, placebo-controlled, randomized trial to determine the safety and efficacy of EMA401 100 mg b.i.d. in reducing 24-hour average pain intensity score in patients with painful diabetic neuropathy (EMPADINE).
A Prospective, Single-Blinded, Dose-Response Study of SCS Therapy using Subthreshold Waveform Patterns in Patients with Chronic Neuropathic Low Back Pain.